American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

CA Cancer Journal for Clinicians

Volumn 66, Issue 1, 2016, Pages 43-73

  Runowicz, Carolyn D ^a   Leach, Corinne R ^b   Henry, N Lynn ^c   Henry, Karen S ^d   Mackey, Heather T ^e   Cowens Alvarado, Rebecca L ^f   Cannady, Rachel S ^b   Pratt Chapman, Mandi L ^g   Edge, Stephen B ^h   Jacobs, Linda A ⁱ   Hurria, Arti ^j   Marks, Lawrence B ^k   Lamonte, Samuel J ^f   Warner, Ellen ^l   Lyman, Gary H ^m   Ganz, Patricia A ⁿ  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b BEHAVIORAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e ONCOLOGY NURSING SOCIETY   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h BAPTIST CANCER CENTER   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF TORONTO   (Canada)

^m Fred Hutchinson Cancer Research Center   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

breast cancer; care coordination; clinical care; follow up; guideline; late effects; long term effects; primary care; quality of life; survivorship; survivorship care plan

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN; GABAPENTIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TRASTUZUMAB;

ANAMNESIS; ANXIETY; ARTICLE; BODY IMAGE; BODY WEIGHT DISORDER; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CANCER SURVIVOR; CAREGIVER SUPPORT; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE SURVEILLANCE; DISTRESS SYNDROME; EARLY DIAGNOSIS; EARLY MENOPAUSE; FAMILY HISTORY; FATIGUE; FEMALE INFERTILITY; GENETIC COUNSELING; HAIR LOSS; HEALTH DISPARITY; HEALTH PROMOTION; HEART DISEASE; HOT FLUSH; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INTERDISCIPLINARY COMMUNICATION; LIBIDO DISORDER; LOW DRUG DOSE; LYMPHEDEMA; MAMMOGRAPHY; MEDICATION COMPLIANCE; MENOPAUSAL SYNDROME; MENSTRUAL IRREGULARITY; MOOD CHANGE; MOUTH DISEASE; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL HEALTH; OBESITY; OSTEOPOROSIS; OVARY INSUFFICIENCY; PAIN; PATIENT COMPLIANCE; PATIENT COUNSELING; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; SECOND CANCER; SEXUAL DYSFUNCTION; SIDE EFFECT; SMOKING CESSATION; SYSTEMATIC REVIEW; VAGINAL DRYNESS; ADULT; AGED; BREAST NEOPLASMS; COMPLICATION; EARLY CANCER DIAGNOSIS; FEMALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NON PROFIT ORGANIZATION; PRACTICE GUIDELINE; PSYCHOLOGY; RISK ASSESSMENT; SURVIVOR; TUMOR RECURRENCE; UNITED STATES; YOUNG ADULT;

ADULT; AGED; AMERICAN CANCER SOCIETY; BODY IMAGE; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENETIC COUNSELING; HUMANS; MEDICAL HISTORY TAKING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PHYSICAL EXAMINATION; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVORS; UNITED STATES; YOUNG ADULT;

EID: 84954368766     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21319     Document Type: Article

References (237)

1. DeSantis CE, Lin CC, Mariotto AB, et al., Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252-271.
2. Howlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2012 [ seer.cancer.gov/csr.1975-2012/, based on the November 2014 SEER data submission, posted to the SEER website April 2015]. Bethesda, MD: National Cancer Institute; 2015.
3. Ganz PA,. Survivorship: adult cancer survivors. Prim Care. 2009; 36: 721-741.
4. Institute of Medicine and National Research Council of the National Academies. From Cancer Patient to Cancer Survivor: Lost in Transition. Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board. Washington, DC: The National Academies Press; 2005.
5. Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: The National Academies Press; 2008.
6. Earle CC, Ganz PA,. Cancer survivorship care: don't let the perfect be the enemy of the good. J Clin Oncol. 2012; 30: 3764-3768.
7. Ganz PA, Earle CC, Goodwin PJ,. J Clin Oncol update on progress in cancer survivorship care and research. J Clin Oncol. 2012; 30: 3655-3656.
8. Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, et al., Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin. 2013; 63: 147-150.
9. ®) Breast Cancer Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. NCCN.org. Accessed April 1, 2015.
10. ®) Survivorship Version 1.2015. © 2015 National Comprehensive Cancer Network, Inc. NCCN.org. Accessed April 1, 2015.
11. Khatcheressian JL, Hurley P, Bantug E, et al., Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 961-965.
12. American Society of Clinical Oncology (ASCO). Cancer Survivorship. asco.org/practice-research/cancer-survivorship. Accessed May 15, 2015.
13. Bower JE,. Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014; 11: 597-609.
14. Hershman DL, Lacchetti C, Dworkin RH, et al., Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014; 32: 1941-1967.
15. Andersen BL, DeRubeis RJ, Berman BS, et al., Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014; 32: 1605-1619.
16. Skolarus TA, Wolf AM, Erb NL, et al., American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014; 64: 225-249.
17. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
18. Jatoi I,. Options in breast cancer local therapy: who gets what? World J Surg. 2012; 36: 1498-1502.
19. Jatoi I, Proschan MA,. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005; 28: 289-294.
20. Kerrigan D, Waters P, Ryan M, et al., Follow-up arrangements for breast cancer patients; is it appropriate to transfer surveillance to general practitioners? Ir Med J. 2014; 107: 273-275.
21. Saslow D, Boetes C, Burke W, et al., American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 75-89.
22. Moyer VA,. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160: 271-281.
23. Rock CL, Doyle C, Demark-Wahnefried W, et al., Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; 62: 242-274.
24. Brawley O, Byers T, Chen A, et al., New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011; 306: 2495-2499.
25. Bower JE, Bak K, Berger A, et al., Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014; 32: 1840-1850.
26. Holland JC, et al., NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Distress Management Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. NCCN.org. Accessed April 1, 2015.
27. Loren AW, Mangu PB, Beck LN, et al., Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 2500-2510.
28. The University of Texas MD Anderson Cancer Center. Survivorship-Invasive Breast Cancer. mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/practice-algorithms/survivorship-breast-invasive-web-algorithm.pdf. Accessed April 7, 2014.
29. Helfand M, Carson S,. US Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Lipid Disorders in Adults: Selective Update of 2001 US Preventive Services Task Force Review. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
30. US Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2011; 154: 356-364.
31. Watts NB, Bilezikian JP, Camacho PM, et al., American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010; 16 (suppl 3): 1-37.
32. Chalasani P, Downey L, Stopeck AT,. Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med. 2010; 123: 489-495.
33. Harris SR, Schmitz KH, Campbell KL, McNeely ML,. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer. 2012; 118: 2312-2324.
34. Stout NL, Binkley JM, Schmitz KH, et al., A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012; 118: 2191-2200.
35. van Londen G, Beckjord E, Dew M, Cuijpers P, Tadic S, Brufsky A,. Breast cancer survivorship symptom management: current perspective and future development. Breast Cancer Manag. 2013; 2: 71-81.
36. Ganz PA, Yip CH, Gralow JR, et al., Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013; 22: 606-615.
37. Centers for Disease Control and Prevention. Vaccines: VPD-VAC/Who Should NOT Get Vaccinated? cdc.gov/vaccines/vpd-vac/should-not-vacc.htm. Accessed August 17, 2015.
38. Rojas MP, Telaro E, Russo A, et al., Follow-up strategies for women treated for early breast cancer [serial online]. Cochrane Database Syst Rev. 2005;(1): CD001768.
39. Salani R, Andersen BL,. Gynecologic care for breast cancer survivors: assisting in the transition to wellness. Am J Obstet Gynecol. 2012; 206: 390-397.
40. Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V,. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994; 271: 1593-1597.
41. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA. 1994; 271: 1587-1592.
42. Henry LN, Hayes DF, Ramsey SD, Hortobagyi GN, Barlow WE, Gralow JR,. Promoting quality and evidence-based care in early-stage breast cancer follow-up [serial online]. J Natl Cancer Inst. 2014; 106: dju034.
43. Ruddy K, Mayer E, Partridge A,. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59: 56-66.
44. Smith RA, Manassaram-Baptiste D, Brooks D, et al., Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015; 65: 30-54.
45. Runowicz CD,. Gynecologic surveillance of women on tamoxifen: first do no harm. J Clin Oncol. 2000; 18: 3457-3458.
46. Falk Dahl CA, Reinertsen KV, Nesvold IL, Fossa SD, Dahl AA,. A study of body image in long-term breast cancer survivors. Cancer. 2010; 116: 3549-3557.
47. Partridge AH,. Cancer survivorship and the young breast cancer patient: addressing the important issues. Oncologist. 2013; 18: e19-e20.
48. Avis NE, Crawford S, Manuel J,. Quality of life among younger women with breast cancer. J Clin Oncol. 2005; 23: 3322-3330.
49. Fobair P, Spiegel D,. Concerns about sexuality after breast cancer. Cancer J. 2009; 15: 19-26.
50. Rosenberg SM, Tamimi RM, Gelber S, et al., Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013; 22: 1849-1855.
51. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL,. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003; 21: 2545-2550.
52. Haddad P, Kalaghchi B, Amouzegar-Hashemi F,. Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial. Radiother Oncol. 2005; 77: 324-326.
53. Magnusson M, Hoglund P, Johansson K, et al., Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer. 2009; 45: 2488-2495.
54. Okunieff P, Augustine E, Hicks JE, et al., Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004; 22: 2207-2213.
55. Scott JL, Kayser K,. A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J. 2009; 15: 48-56.
56. Armer JM,. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005; 23: 76-83.
57. Armer JM, Stewart BR,. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010; 43: 118-127.
58. Radina ME, Armer JM, Stewart BR,. Making self-care a priority for women at risk of breast cancer-related lymphedema. J Fam Nurs. 2014; 20: 226-249.
59. Krag DN, Anderson SJ, Julian TB, et al., Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010; 11: 927-933.
60. Warren LE, Miller CL, Horick N, et al., The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014; 88: 565-571.
61. Fu MR, Rosedale M,. Breast cancer survivors' experiences of lymphedema-related symptoms. J Pain Symptom Manage. 2009; 38: 849-859.
62. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the international society of lymphology. Lymphology. 2013; 46: 1-11.
63. Shaitelman SF, Cromwell KD, Rasmussen JC, et al., Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015; 65: 55-81.
64. Ostby PL, Armer JM, Dale PS, Van Loo MJ, Wilbanks CL, Stewart BR,. Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema. J Pers Med. 2014; 4: 424-447.
65. Coriddi M, Khansa I, Stephens J, Miller M, Boehmler J, Tiwari P,. Analysis of factors contributing to severity of breast cancer-related lymphedema. Ann Plast Surg. 2015; 74: 22-25.
66. Schmitz KH, Ahmed RL, Troxel AB, et al., Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010; 304: 2699-2705.
67. Cemal Y, Pusic A, Mehrara BJ,. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg. 2011; 213: 543-551.
68. Ahmed RL, Thomas W, Yee D, Schmitz KH,. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006; 24: 2765-2772.
69. Dominick SA, Natarajan L, Pierce JP, Madanat H, Madlensky L,. Patient compliance with a health care provider referral for an occupational therapy lymphedema consult. Support Care Cancer. 2014; 22: 1781-1787.
70. Darby SC, Ewertz M, McGale P, et al., Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368: 987-998.
71. Barton M,. Cholesterol and atherosclerosis: modulation by oestrogen. Curr Opin Lipidol. 2013; 24: 214-220.
72. Chalasani P, Livingston R,. Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a review. Oncologist. 2013; 18: 909-916.
73. Curigliano G, Cardinale D, Suter T, et al., Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012; 23: vii155-vii166.
74. Bell LN, Nguyen AT, Li L, et al., Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole. J Clin Pharmacol. 2012; 52: 1852-1860.
75. Mouridsen H, Giobbie-Hurder A, Goldhirsch A, et al., Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med. 2009; 361: 766-776.
76. Stan D, Loprinzi CL, Ruddy KJ,. Breast cancer survivorship issues. Hematol Oncol Clin North Am. 2013; 27: 805-827, ix.
77. Von Ah D, Habermann B, Carpenter JS, Schneider BL,. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013; 17: 236-241.
78. Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR,. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011; 38: 431-438.
79. Reid-Arndt SA, Yee A, Perry MC, Hsieh C,. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol. 2009; 27: 415-434.
80. Reuter-Lorenz P, Cimprich B,. Cognitive function and breast cancer: promise and potential insights from functional brain imaging. Breast Cancer Res Treat. 2013; 137: 33-43.
81. Bruno J, Hosseini SM, Kesler S,. Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis. 2012; 48: 329-338.
82. Dumas JA, Makarewicz J, Schaubhut GJ, et al., Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav. 2013; 7: 524-532.
83. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA,. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005; 59: 60-70.
84. Hurria A, Lachs M,. Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Res Treat. 2007; 103: 259-268.
85. Ganz PA, Petersen L, Castellon SA, et al., Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study. J Clin Oncol. 2014; 32: 3559-3567.
86. Ahles TA, Saykin AJ, McDonald BC, et al., Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010; 28: 4434-4440.
87. Ahles TA, Saykin AJ,. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer. 2002; 3 (suppl 3): S84-S90.
88. Small BJ, Rawson KS, Walsh E, et al., Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer. 2011; 117: 1369-1376.
89. Kohli S, Fisher SG, Tra Y, et al., The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009; 115: 2605-2616.
90. Von Ah D, Jansen C, Allen DH, Schiavone RM, Wulff J,. Putting evidence into practice: evidence-based interventions for cancer and cancer treatment-related cognitive impairment. Clin J Oncol Nurs. 2011; 15: 607-615.
91. Von Ah D, Carpenter JS, Saykin A, et al., Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2012; 135: 799-809.
92. Ercoli LM, Petersen L, Hunter AM, et al., Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial [published online ahead of print March 10, 2015 ]. Psychooncology. doi: 10.1002/pon.3769.
93. Siegel R, Desantis C, Jemal A,. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117.
94. Simard S, Thewes B, Humphris G, et al., Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7: 300-322.
95. Boyes AW, Girgis A, Zucca AC, Lecathelinais C,. Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey [comment]. Med J Aust. 2009; 191: 295.
96. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK,. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med. 2009; 169: 1274-1281.
97. McGinty HL, Goldenberg JL, Jacobsen PB,. Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psychooncology. 2012; 21: 203-210.
98. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P,. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013; 14: 721-732.
99. Zainal NZ, Nik-Jaafar NR, Baharudin A, Sabki ZA, Ng CG,. Prevalence of depression in breast cancer survivors: a systematic review of observational studies. Asian Pac J Cancer Prev. 2013; 14: 2649-2656.
100. Patel D, Sharpe L, Thewes B, Bell ML, Clarke S,. Using the Distress Thermometer and Hospital Anxiety and Depression Scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. J Affect Disord. 2011; 131: 412-416.
101. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
102. Spitzer RL, Kroenke K, Williams JB, Lowe B,. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166: 1092-1097.
103. Ewertz M, Jensen AB,. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011; 50: 187-193.
104. Ha EH, Cho YK,. The mediating effects of self-esteem and optimism on the relationship between quality of life and depressive symptoms of breast cancer patients. Psychiatry Investig. 2014; 11: 437-445.
105. Rosen RC, Lane RM, Menza M,. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999; 19: 67-85.
106. Speer JJ, Hillenberg B, Sugrue DP, et al., Study of sexual functioning determinants in breast cancer survivors. Breast J. 2005; 11: 440-447.
107. Casellas-Grau A, Font A, Vives J,. Positive psychology interventions in breast cancer. A systematic review. Psychooncology. 2014; 23: 9-19.
108. Bower JE,. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008; 26: 768-777.
109. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH,. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999; 18: 233-242.
110. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, Kennedy MJ,. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract. 1999; 7: 240-247.
111. Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R,. Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis [serial online]. BMC Cancer. 2015; 15: 77.
112. Gielissen MF, Verhagen CA, Bleijenberg G,. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer. 2007; 97: 612-618.
113. Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK,. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors-a meta-analysis. Psychooncology. 2011; 20: 115-126.
114. Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T,. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer. 1999; 79: 1179-1181.
115. Chen Z, Maricic M, Bassford TL, et al., Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med. 2005; 165: 552-558.
116. Chen Z, Maricic M, Pettinger M, et al., Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer. 2005; 104: 1520-1530.
117. Lindsey AM, Gross G, Twiss J, Waltman N, Ott C, Moore TE,. Postmenopausal survivors of breast cancer at risk for osteoporosis: nutritional intake and body size. Cancer Nurs. 2002; 25: 50-56.
118. Gralow JR, Biermann JS, Farooki A, et al., NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw. 2013; 11 (suppl 3): S1-S50; quiz S51.
119. Johnell O, Kanis JA, Oden A, et al., Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 1185-1194.
120. Kanis JA, Borgstrom F, De Laet C, et al., Assessment of fracture risk. Osteoporos Int. 2005; 16: 581-589.
121. Feskanich D, Willett W, Colditz G,. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA. 2002; 288: 2300-2306.
122. Moyer VA,. Prevention of falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 197-204.
123. Cosman F, de Beur SJ, LeBoff MS, et al., Clinican's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25: 2359-2381.
124. Chapuy MC, Arlot ME, Duboeuf F, et al., Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992; 327: 1637-1642.
125. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE,. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997; 337: 670-676.
126. Murad MH, Elamin KB, Abu Elnour NO, et al., Clinical review: the effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011; 96: 2997-3006.
127. Greenspan SL, Nelson JB, Trump DL, Resnick NM,. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial. Ann Intern Med. 2007; 146: 416-424.
128. Van Poznak C,. Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition [serial online]. Breast Cancer Res. 2010; 12: 110.
129. Van Poznak C, Hannon RA, Mackey JR, et al., Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. J Clin Oncol. 2010; 28: 967-975.
130. Baum M, Budzar AU, Cuzick J, et al., Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002; 359: 2131-2139.
131. Stubblefield MD, Keole N,. Upper body pain and functional disorders in patients with breast cancer. PM R. 2014; 6: 170-183.
132. Harrington S, Padua D, Battaglini C, et al., Comparison of shoulder flexibility, strength, and function between breast cancer survivors and healthy participants. J Cancer Surviv. 2011; 5: 167-174.
133. Fenlon D, Addington-Hall JM, O'Callaghan AC, Clough J, Nicholls P, Simmonds P,. A survey of joint and muscle aches, pain, and stiffness comparing women with and without breast cancer. J Pain Symptom Manage. 2013; 46: 523-535.
134. Karki A, Simonen R, Malkia E, Selfe J,. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med. 2005; 37: 180-188.
135. Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI,. Objective assessment of axillary morbidity in breast cancer treatment. Am Surg. 1999; 65: 995-998.
136. Kuehn T, Klauss W, Darsow M, et al., Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000; 64: 275-286.
137. Crew KD, Greenlee H, Capodice J, et al., Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol. 2007; 25: 3877-3883.
138. Henry NL, Azzouz F, Desta Z, et al., Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol. 2012; 30: 936-942.
139. Hershman DL, Kushi LH, Shao T, et al., Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010; 28: 4120-4128.
140. Barron TI, Cahir C, Sharp L, Bennett K,. A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer. Br J Cancer. 2013; 109: 1513-1521.
141. De Groef A, Van Kampen M, Dieltjens E, et al., Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil. 2015; 96: 1140-1153.
142. Loh SY, Musa AN,. Methods to improve rehabilitation of patients following breast cancer surgery: a review of systematic reviews. Breast Cancer (Dove Med Press). 2015; 7: 81-98.
143. Irwin ML, Cartmel B, Gross CP, et al., Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015; 33: 1104-1111.
144. Crew KD, Capodice JL, Greenlee H, et al., Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol. 2010; 28: 1154-1160.
145. Andersen KG, Kehlet H,. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011; 12: 725-746.
146. Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H,. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009; 302: 1985-1992.
147. Pachman DR, Barton DL, Watson JC, Loprinzi CL,. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011; 90: 377-387.
148. Steegers MA, Snik DM, Verhagen AF, van der Drift MA, Wilder-Smith OH,. Only half of the chronic pain after thoracic surgery shows a neuropathic component. J Pain. 2008; 9: 955-961.
149. Garcia MK, McQuade J, Haddad R, et al., Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013; 31: 952-960.
150. Mishra SI, Scherer RW, Geigle PM, et al., Exercise interventions on health-related quality of life for cancer survivors [serial online]. Cochrane Database Syst Rev. 2012;(8): CD007566.
151. Courneya KS, McKenzie DC, Mackey JR, et al., Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy. Br J Cancer. 2014; 111: 1718-1725.
152. Smith E, Pang H, Cirrincione C, et al., Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013; 309: 1359-1367.
153. Kort JD, Eisenberg ML, Millheiser LS, Westphal LM,. Fertility issues in cancer survivorship. CA Cancer J Clin. 2014; 64: 118-134.
154. Ganz PA, Land SR, Geyer CE Jr, et al., Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. J Clin Oncol. 2011; 29: 1110-1116.
155. Rosen MP, Sternfeld B, Schuh-Huerta SM, Reijo Pera RA, McCulloch CE, Cedars MI,. Antral follicle count: absence of significant midlife decline. Fertil Steril. 2010; 94: 2182-2185.
156. Sadovsky R, Basson R, Krychman M, et al., Cancer and sexual problems. J Sex Med. 2010; 7: 349-373.
157. Berkey FJ,. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010; 82: 381-388, 394.
158. Mazzarello S, Hutton B, Ibrahim MF, et al., Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat. 2015; 152: 1-8.
159. Pruthi S, Simon JA, Early AP,. Current overview of the management of urogenital atrophy in women with breast cancer. Breast J. 2011; 17: 403-408.
160. Kendall A, Dowsett M, Folkerd E, Smith I,. Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol. 2006; 17: 584-587.
161. Rowland JH, Meyerowitz BE, Crespi CM, et al., Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat. 2009; 118: 99-111.
162. Murthy V, Chamberlain RS,. Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution. Cancer Control. 2012; 19: 317-329.
163. Kaplan M, Mahon S, Cope D, Keating E, Hill S, Jacobson M,. Putting evidence into practice: evidence-based interventions for hot flashes resulting from cancer therapies. Clin J Oncol Nurs. 2011; 15: 149-157.
164. Jin Y, Desta Z, Stearns V, et al., CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst. 2005; 97: 30-39.
165. Burstein HJ, Prestrud AA, Seidenfeld J, et al., American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010; 28: 3784-3796.
166. Loprinzi CL, Sloan J, Stearns V, et al., Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009; 27: 2831-2837.
167. Bordeleau L, Pritchard KI, Loprinzi CL, et al., Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol. 2010; 28: 5147-5152.
168. Pandya KJ, Morrow GR, Roscoe JA, et al., Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005; 366: 818-824.
169. Clayden JR, Bell JW, Pollard P,. Menopausal flushing: double-blind trial of a non-hormonal medication. BMJ. 1974; 1: 409-412.
170. Chiu HY, Shyu YK, Chang PC, Tsai PS,. Effects of acupuncture on menopause-related symptoms in breast cancer survivors: a meta-analysis of randomized controlled trials [published online ahead of print June 3, 2015 ]. Cancer Nurs. doi: 10.1097/NCC.0000000000000278.
171. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C,. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther. 2007; 29: 230-241.
172. Chan DS, Vieira AR, Aune D, et al., Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014; 25: 1901-1914.
173. Protani M, Coory M, Martin JH,. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010; 123: 627-635.
174. McTiernan A, Irwin M, Vongruenigen V,. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 2010; 28: 4074-4080.
175. Wei EK, Wolin KY, Colditz GA,. Time course of risk factors in cancer etiology and progression. J Clin Oncol. 2010; 28: 4052-4057.
176. Patterson RE, Cadmus LA, Emond JA, Pierce JP,. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas. 2010; 66: 5-15.
177. Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E,. Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat. 2009; 114: 13-22.
178. Friedenreich CM,. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res. 2011; 188: 125-139.
179. Barbaric M, Brooks E, Moore L, Cheifetz O,. Effects of physical activity on cancer survival: a systematic review. Physiother Can. 2010; 62: 25-34.
180. Carmichael AR, Daley AJ, Rea DW, Bowden SJ,. Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction. Eur J Surg Oncol. 2010; 36: 1139-1148.
181. Speed-Andrews AE, Courneya KS,. Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep. 2009; 8: 176-181.
182. Irwin ML, Mayne ST,. Impact of nutrition and exercise on cancer survival. Cancer J. 2008; 14: 435-441.
183. Lahart IM, Metsios GS, Nevill AM, Carmichael AR,. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015; 54: 635-654.
184. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM,. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012; 104: 815-840.
185. Binkley JM, Harris SR, Levangie PK, et al., Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 2012; 118: 2207-2216.
186. Cappiello M, Cunningham RS, Knobf MT, Erdos D,. Breast cancer survivors: information and support after treatment. Clin Nurs Res. 2007; 16: 278-293; discussion 294-301.
187. Bloom JR, Stewart SL, Chang S, Banks PJ,. Then and now: quality of life of young breast cancer survivors. Psychooncology. 2004; 13: 147-160.
188. Blank TO, Bellizzi KM,. A gerontologic perspective on cancer and aging. Cancer. 2008; 112: 2569-2576.
189. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL,. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012; 104: 386-405.
190. Stricker CT, Jacobs LA, Risendal B, et al., Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011; 5: 358-370.
191. Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ,. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer. 2014; 111: 1899-1908.
192. Mayer DK, Birken SA, Check DK, Chen RC,. Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013). Cancer. 2015; 121: 978-996.
193. Grunfeld E, Julian JA, Pond G, et al., Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011; 29: 4755-4762.
194. Brothers BM, Easley A, Salani R, Andersen BL,. Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013; 129: 554-558.
195. Hershman DL, Greenlee H, Awad D, et al., Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013; 138: 795-806.
196. Ezendam NP, Nicolaije KA, Kruitwagen RF, et al., Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial. J Cancer Surviv. 2014; 8: 595-602.
197. Irwin ML, McTiernan A, Bernstein L, et al., Physical activity levels among breast cancer survivors. Med Sci Sports Exerc. 2004; 36: 1484-1491.
198. Demark-Wahnefried W, Rogers LQ, Alfano CM, et al., Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin. 2015; 65: 167-189.
199. Ligibel JA, Alfano CM, Courneya KS, et al., American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014; 32: 3568-3574.
200. US Preventive Services Task Force. Obesity in Adults: Screening and Management, June 2012. uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/obesity-in-adults-screening-and-management#references. Accessed August 17, 2015.
201. Underwood JM, Townsend JS, Stewart SL, et al., Surveillance of demographic characteristics and health behaviors among adult cancer survivors-Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ. 2012; 61: 1-23.
202. Schmid D, Leitzmann MF,. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014; 25: 1293-1311.
203. Zhao G, Li C, Okoro CA, et al., Trends in modifiable lifestyle-related risk factors following diagnosis in breast cancer survivors. J Cancer Surviv. 2013; 7: 563-569.
204. Blanchard CM, Courneya KS, Stein K,. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol. 2008; 26: 2198-2204.
205. Forbes CC, Blanchard CM, Mummery WK, Courneya K,. Prevalence and correlates of strength exercise among breast, prostate, and colorectal cancer survivors. Oncol Nurs Forum. 2015; 42: 118-127.
206. Irwin ML, McTiernan A, Manson JE, et al., Physical activity and survival in postmenopausal women with breast cancer: results from the Women's Health Initiative. Cancer Prev Res (Phila). 2011; 4: 522-529.
207. Kroenke CH, Fung TT, Hu FB, Holmes MD,. Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol. 2005; 23: 9295-9303.
208. Kwan ML, Weltzien E, Kushi LH, Castillo A, Slattery ML, Caan BJ,. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009; 27: 919-926.
209. Vrieling A, Buck K, Seibold P, et al., Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer. 2013; 108: 188-192.
210. Chlebowski RT, Blackburn GL, Thomson CA, et al., Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98: 1767-1776.
211. Pierce JP, Natarajan L, Caan BJ, et al., Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007; 298: 289-298.
212. American Cancer Society. Alcohol Use and Cancer. cancer.org/cancer/cancercauses/dietandphysicalactivity/alcohol-use-and-cancer. Accessed January 6, 2015.
213. McGuire S,. US Department of Agriculture and US Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th edition, Washington, DC: US Government Printing Office, January 2011. Adv Nutr. 2011; 2: 293-294.
214. Kwan ML, Kushi LH, Weltzien E, et al., Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010; 28: 4410-4416.
215. Baan R, Straif K, Grosse Y, et al., Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007; 8: 292-293.
216. Nelson DE, Jarman DW, Rehm J, et al., Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health. 2013; 103: 641-648.
217. Scoccianti C, Lauby-Secretan B, Bello PY, Chajes V, Romieu I,. Female breast cancer and alcohol consumption: a review of the literature. Am J Prev Med. 2014; 46 (3 suppl 1): S16-S25.
218. Terry MB, Zhang FF, Kabat G, et al., Lifetime alcohol intake and breast cancer risk. Ann Epidemiol. 2006; 16: 230-240.
219. Berube S, Lemieux J, Moore L, Maunsell E, Brisson J,. Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis [serial online]. Breast Cancer Res. 2014; 16: R42.
220. Nayan S, Gupta MK, Strychowsky JE, Sommer DD,. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013; 149: 200-211.
221. Boekhout AH, Maunsell E, Pond GR, et al., A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial [published online ahead of print April 21, 2015 ]. J Cancer Surviv. doi: 10.1007/s11764-015-0443-1.
222. Mao JJ, Bowman MA, Stricker CT, et al., Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009; 27: 933-938.
223. Shulman LN, Jacobs LA, Greenfield S, et al., Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract. 2009; 5: 119-123.
224. Travis LB, Yahalom J,. Cancer Survivorship. Preface. Hematol Oncol Clin North Am. 2008; 22: xi-xii.
225. Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. survivorshipguidelines.org. Accessed May 15, 2015.
226. Grunfeld E, Levine MN, Julian JA, et al., Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006; 24: 848-855.
227. Grunfeld E, Fitzpatrick R, Mant D, et al., Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract. 1999; 49: 705-710.
228. Dawes AJ, Hemmelgarn M, Nguyen DK, et al., Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer. 2015; 121: 1249-1256.
229. Palmer SC, Stricker CT, Panzer SL, et al., Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial [serial online]. J Oncol Pract. 2015; 11: e222-e229.
230. Kim Y, Kashy DA, Spillers RL, Evans TV,. Needs assessment of family caregivers of cancer survivors: three cohorts comparison. Psychooncology. 2010; 19: 573-582.
231. Kim Y, Spillers RL, Hall DL,. Quality of life of family caregivers 5 years after a relative's cancer diagnosis: follow-up of the national quality of life survey for caregivers. Psychooncology. 2012; 21: 273-281.
232. Given BA, Given CW, Sherwood PR,. Family and caregiver needs over the course of the cancer trajectory. J Support Oncol. 2012; 10: 57-64.
233. National Center for Chronic Disease Prevention and Health Promotion,. United States Cancer Statistics: 1999-2011 Incidence and Mortality [web-based report]. nccd.cdc.gov/uscs/. Accessed April 1, 2015.
234. American Cancer Society. Cancer Facts & Figures for African Americans 2013-2014. Atlanta, GA: American Cancer Society; 2013.
235. National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program. SEER Cancer Statistics Review, 1975-2011. seer.cancer.gov/archive/csr/1975-2011/. Accessed April 1, 2015.
236. Mead H, Cartwright-Smith L, Jones K, Ramos C, Woods K, Siegel B,. Racial and Ethnic Disparities in US Health Care: A Chartbook. New York, NY: The Commonwealth Fund; 2008.
237. American Geriatrics Society Expert Panel on the Care of Older Adults With Multimorbidity. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: J Am Geriatr Soc. 2012; 60: 1957-1968.